Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jon C Aster

Showing results (11-20 of 225) with videos related to

Pageof 23
Sort By:
Current Opinion in Genetics & Development|April 28, 2004
Multiple niches for Notch in cancer: context is everythingAndrew P Weng, Jon C Aster
Cancer Cell|January 7, 2004
No T without D3: a critical role for cyclin D3 in normal and malignant precursor T cellsAndrew P Weng, Jon C Aster
Current Opinion in Hematology|November 19, 2004
T cell acute lymphoblastic leukemia/lymphoma: a human cancer commonly associated with aberrant NOTCH1 signalingWarren S Pear, Jon C Aster
The American Journal of Pathology|March 14, 2002
Detection of BCL2 rearrangements in follicular lymphomaJon C Aster, Janina A Longtine
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2012
Targeting the Notch pathway: twists and turns on the road to rational therapeuticsJon C Aster, Stephen C Blacklow
Methods in Molecular Biology (Clifton, N.J.)|July 24, 2014
Application and evaluation of anti-Notch antibodies to modulate Notch signalingWendy R Gordon, Jon C Aster
Immunological Reviews|October 9, 2002
Notch signaling in hematopoiesis and early lymphocyte developmentDavid Allman, Jon C Aster, Warren S Pear
Current Opinion in Chemical Biology|July 23, 2002
Notch signaling as a therapeutic targetYunsun Nam, Jon C Aster, Stephen C Blacklow
Current Opinion in Genetics & Development|December 21, 2006
The multifaceted role of Notch in cancerMonideepa Roy, Warren S Pear, Jon C Aster
Annual Review of Pathology|November 28, 2007
Notch signaling in leukemiaJon C Aster, Warren S Pear, Stephen C Blacklow
Pageof 23

Showing results (11-20 of 225) with videos related to

Sort By:
Pageof 23
Current Opinion in Genetics & Development|April 28, 2004
Multiple niches for Notch in cancer: context is everythingAndrew P Weng, Jon C Aster
Cancer Cell|January 7, 2004
No T without D3: a critical role for cyclin D3 in normal and malignant precursor T cellsAndrew P Weng, Jon C Aster
Current Opinion in Hematology|November 19, 2004
T cell acute lymphoblastic leukemia/lymphoma: a human cancer commonly associated with aberrant NOTCH1 signalingWarren S Pear, Jon C Aster
The American Journal of Pathology|March 14, 2002
Detection of BCL2 rearrangements in follicular lymphomaJon C Aster, Janina A Longtine
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2012
Targeting the Notch pathway: twists and turns on the road to rational therapeuticsJon C Aster, Stephen C Blacklow
Methods in Molecular Biology (Clifton, N.J.)|July 24, 2014
Application and evaluation of anti-Notch antibodies to modulate Notch signalingWendy R Gordon, Jon C Aster
Immunological Reviews|October 9, 2002
Notch signaling in hematopoiesis and early lymphocyte developmentDavid Allman, Jon C Aster, Warren S Pear
Current Opinion in Chemical Biology|July 23, 2002
Notch signaling as a therapeutic targetYunsun Nam, Jon C Aster, Stephen C Blacklow
Current Opinion in Genetics & Development|December 21, 2006
The multifaceted role of Notch in cancerMonideepa Roy, Warren S Pear, Jon C Aster
Annual Review of Pathology|November 28, 2007
Notch signaling in leukemiaJon C Aster, Warren S Pear, Stephen C Blacklow
Pageof 23